R&D Tax Incentives

R&D Tax Incentives Hong Kong — Section 16B

Hong Kong's enhanced R&D deduction allows up to 300% deduction on qualifying R&D expenditure. Most companies significantly underutilise this — leaving hundreds of thousands on the table every year.

HKICPA登録済み 24時間対応 固定料金制 100%秘密厳守
無料相談を受ける
300% Enhanced deduction rate (first HKD 2M)
200% Rate on expenditure above HKD 2M
100% Basic deduction (all qualifying R&D)

R&D Tax Incentives

Hong Kong's enhanced R&D deduction allows up to 300% deduction on qualifying R&D expenditure. Most companies significantly underutilise this — leaving hundreds of thousands on the table every year.

⚠️

⚠ Most HK Companies Underclaim R&D Deductions

IRD's DIPN 49 defines qualifying R&D broadly — including software development, product improvement, and process R&D. Many companies expense R&D without claiming the enhanced deduction, missing the uplift that turns a 16.5% deduction into a 300% deduction on the first HKD 2 million.

よくあるお悩み

以下の税務問題でお困りではありませんか?

Identifying Qualifying Expenditure

Not all R&D spending qualifies for the enhanced rate. Wages, equipment, and contracted research at prescribed institutions qualify; market research and routine testing do not.

⚠ Risk: Overclaiming non-qualifying spend → IRD disallowance + penalties

Prescribed Research Institutions

The 300%/200% enhanced rate applies only to R&D outsourced to prescribed research institutions (universities, innovation centres). Internal R&D gets 100% only unless the enhanced conditions are met.

⚠ Risk: Missing prescribed institution qualification → claiming 100% instead of 300%

Documentation Requirements

IRD requires detailed records of R&D activities, project purpose, qualifying expenditure categorisation, and staff time allocation to support enhanced deduction claims.

⚠ Risk: Poor documentation → IRD rejects enhanced claim on audit

IP Ownership Requirement

For the enhanced rate, the R&D must be related to a trade or business carried on in HK, and any resulting IP should be owned or co-owned by the HK entity.

⚠ Risk: IP owned offshore → HK entity loses enhanced deduction entitlement
対象者

対象となるお客様

Technology and software companies

Companies developing proprietary software, apps, or platforms in HK.

Pharmaceutical and biotech firms

Life sciences companies conducting drug research, clinical trials, or formulation development.

Manufacturing companies with product R&D

Manufacturers improving products or production processes through systematic R&D.

Companies partnering with HK universities

Businesses with research collaborations with HKUST, HKU, CUHK, or PolyU.

サービス内容

サービス内容

R&D Expenditure Review

Analyse all R&D expenditure to identify qualifying amounts for the basic and enhanced deductions under s.16B IRO.

Per DIPN 49 guidance

Enhanced Deduction Claim

Prepare the R&D enhanced deduction claim for inclusion in the profits tax return, with full documentation package.

Project summaries + expenditure schedules

Prescribed Institution Structuring

Advise on how to structure R&D partnerships with HK prescribed research institutions to maximise the 300% rate.

University collaboration agreement review

R&D Tax Planning Strategy

Develop a multi-year R&D tax strategy — identifying optimal project structures, expenditure timing, and IP ownership arrangements.

Linked to patent box planning
ご利用の流れ

シンプル・効率的・プロフェッショナル

1

R&D Activity Mapping

Interview technical and finance teams to map all qualifying R&D activities and expenditure.

1-2 weeks
2

Qualifying Expenditure Analysis

Categorise expenditure by qualifying type and calculate basic vs enhanced claim.

1 week
3

Documentation Preparation

Prepare R&D project summaries and supporting documentation for IRD.

1-2 weeks
4

Annual Review

Annual review to capture new R&D activity and update the deduction claim.

Annual
ご相談はお気軽に 義務なし・キャンセル自由
無料相談を予約する
お客様の成功事例

実際のクライアントへの実績

Case Study

Fintech company — software R&D enhanced claim

HKD 660,000 節約額
  • HKD 3.8M annual R&D expenditure identified
  • HKD 2M restructured to HKUST collaboration (300% rate)
  • Additional HKD 1.8M claimed at 200% rate
  • Total deduction: HKD 9.6M vs HKD 3.8M expensed
"We were expensing R&D but never claiming the enhanced deduction. That changes everything."
C
確認済みクライアント Case Study
Case Study

Medical device manufacturer — R&D + patent box combo

HKD 1,100,000 節約額
  • R&D enhanced deduction HKD 580K annual saving
  • Patent box 5% rate on resulting royalty income
  • IP ownership confirmed in HK entity
  • DEMPE substance documented for BEPS compliance
"The combined R&D deduction and patent box saved us seven figures annually."
C
確認済みクライアント Case Study
★★★★★ 2,400+ 名以上のお客様にご信頼いただいています
無料相談を受ける

無料専門家相談

今すぐシニア税務専門家にご相談ください

  • 30分間の無料初回相談
  • シニアCPAが担当いたします
  • 義務なし・キャンセル自由
HKICPA 登録 24時間以内に返答 義務なし
選ばれる理由

TAX.hk を選ぶ理由

香港税務の深い専門知識

当社の公認会計士は15年以上の香港税務経験を有し、税務局の最新情報を常に把握しています。

透明な固定料金

時間単位の請求による予期せぬ費用はありません。開始前に費用を明確にご提示します。

24時間以内の回答

すべてのお問い合わせに1営業日以内にご返答します。緊急案件は4時間以内に対応いたします。

厳格な秘密保持

すべてのお客様情報は、厳格な職業上の守秘義務に基づき管理されています。

よくある質問

よくある質問

ご質問への迅速な回答

Qualifying R&D under s.16B(1) includes activities that are innovative, involve technical uncertainty, are systematic or investigative in nature, and aim to advance knowledge or create new/improved products, processes, or services. Routine product testing, market research, and quality control do NOT qualify.
The first HKD 2 million of qualifying R&D expenditure paid to a prescribed research institution attracts a 300% deduction — meaning a HKD 2M payment reduces assessable profits by HKD 6M. Expenditure above HKD 2M at a prescribed institution attracts 200%. In-house R&D qualifies for 100% (basic deduction only), plus potentially 200% if conditions met.
The list of prescribed research institutions includes the eight HK universities (HKU, CUHK, HKUST, PolyU, CityU, HKBU, HSUHK, EdUHK), various government-funded R&D centres, and other approved institutions listed in Schedule 45 of IRO. The list is updated periodically.
Only if the Mainland lab is a prescribed research institution under HK law — which most are not. For non-prescribed institution outsourcing, only the basic 100% deduction applies (if the expenditure otherwise qualifies). Subcontracting R&D to overseas non-prescribed labs does not attract enhanced rates.
Yes. Capital expenditure on R&D assets (equipment, machinery used for R&D) qualifies for capital allowances under s.16B(3), not the enhanced revenue deduction. Revenue expenditure (staff costs, consumables, payments to research institutions) qualifies for the enhanced deduction. The distinction requires careful analysis.
R&D deductions that cannot be utilised in the year because the company has insufficient profits can be carried forward indefinitely under s.19C IRO and offset against future profits. This makes early-stage R&D expenditure valuable even when the company is loss-making.

ご相談はお気軽に

香港の上級税務専門家との無料相談を今すぐご予約ください。

このページは一般的な情報提供を目的としています。お客様の具体的な状況に応じたアドバイスについては、資格を持つ香港の税務専門家にご相談ください。